Congress Wealth Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$165K Sell
22,540
-59,050
-72% -$477K ﹤0.01% 1149
2025
Q1
$775K Buy
+81,590
New +$1.02M 0.01% 692

Other funds holding NEO

Congress Wealth Management's NEO Position: Q2 2025 in Review

Congress Wealth Management reduced its NeoGenomics (NEO) stake by 72% in Q2 2025, selling an estimated $477K and leaving 22,540 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #1149.

Congress Wealth Management first reported a position in NEO in Q1 2025 and has held it in 2 quarters since. The position peaked at $775K in Q1 2025. 274 funds tracked by Wall St. Rank hold NEO as of Q2 2025.

  • Congress Wealth Management held 22,540 shares of NeoGenomics worth $165K as of Q2 2025.
  • Congress Wealth Management sold 59,050 NeoGenomics shares in Q2 2025, an estimated $477K.
  • NeoGenomics made up ﹤0.01% of Congress Wealth Management's portfolio in Q2 2025, its #1149 holding.
  • Congress Wealth Management first reported a position in NeoGenomics in Q1 2025 and has held it in 2 quarters since.
  • Congress Wealth Management's NeoGenomics position peaked at $775K in Q1 2025.
  • 274 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2025.

Based on Congress Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.